[HTML][HTML] Effect of anakinra on mortality in patients with COVID-19: a systematic review and patient-level meta-analysis
… might improve the prognosis of patients with moderate to severe COVID-19 (ie, patients …
the effect of anakinra treatment on mortality in patients admitted to hospital with COVID-19. …
the effect of anakinra treatment on mortality in patients admitted to hospital with COVID-19. …
[HTML][HTML] The effect of anakinra in hospitalized patients with COVID-19: an updated systematic review and meta-analysis
… COVID-19 and hyperinflammation. An updated systematic review and meta-analysis regarding
the impact of anakinra on … of anakinra in the treatment of selected patients with COVID-19. …
the impact of anakinra on … of anakinra in the treatment of selected patients with COVID-19. …
Current evidence on the use of anakinra in COVID-19
… in COVID-19 due to its great safety profile. Considering the beneficial effects of anakinra in
… aimed to review the literature to define which COVID-19 patients benefit most from anakinra. …
… aimed to review the literature to define which COVID-19 patients benefit most from anakinra. …
[HTML][HTML] Effect of anakinra versus usual care in adults in hospital with COVID-19 and mild-to-moderate pneumonia (CORIMUNO-ANA-1): a randomised controlled trial
PL Tharaux, G Pialoux, A Pavot, X Mariette… - The Lancet …, 2021 - thelancet.com
… Patients with COVID-19 pneumonia have an … anakinra, a recombinant human IL-1 receptor
antagonist, could improve outcomes in patients in hospital with mild-to-moderate COVID-19 …
antagonist, could improve outcomes in patients in hospital with mild-to-moderate COVID-19 …
[HTML][HTML] Anakinra for severe forms of COVID-19: a cohort study
T Huet, H Beaussier, O Voisin… - The Lancet …, 2020 - thelancet.com
… among patients with COVID-19. We aimed to assess the off-label use of anakinra in patients
who were admitted to hospital for severe forms of COVID-19 with symptoms indicative of …
who were admitted to hospital for severe forms of COVID-19 with symptoms indicative of …
[HTML][HTML] Anakinra treatment in critically ill COVID-19 patients: a prospective cohort study
EJ Kooistra, NJB Waalders, I Grondman, NAF Janssen… - Critical care, 2020 - Springer
… In the present study, the effects of anakinra in critically ill COVID-19 patients with clinical
features of MAS/hyperinflammation were compared to critically ill COVID-19 patients that did not …
features of MAS/hyperinflammation were compared to critically ill COVID-19 patients that did not …
[HTML][HTML] Anakinra for the treatment of COVID-19 patients: a systematic review and meta-analysis
K Dahms, A Mikolajewska, K Ansems… - European journal of …, 2023 - Springer
… Anakinra for the treatment of COVID-19 patients with elevated soluble urokinase plasminogen
activator receptor (suPAR). However, the role of Anakinra in COVID-19 … effects of Anakinra …
activator receptor (suPAR). However, the role of Anakinra in COVID-19 … effects of Anakinra …
Anakinra for severe forms of COVID-19
NA Khan - The Lancet Rheumatology, 2020 - thelancet.com
… the effects of the interleukin1 receptor antag onist anakinra in patients with severe COVID19
with … a group of patients with severe COVID19 treated with anakinra plus standard of care (…
with … a group of patients with severe COVID19 treated with anakinra plus standard of care (…
Systematic review and meta-analysis of anakinra, sarilumab, siltuximab and tocilizumab for COVID-19
… therapies in the management of COVID-19. We have established that evidence for the
efficacy of anakinra, siltuximab or sarilumab in COVID-19 is currently insufficient and adequately …
efficacy of anakinra, siltuximab or sarilumab in COVID-19 is currently insufficient and adequately …
Effect of anakinra in COVID-19
EJ Kooistra, NJB Waalders, M Kox… - The Lancet …, 2020 - thelancet.com
… Therefore, it would be interesting to learn if the effects of anakinra observed in the study
by … for using anakinra in the treatment of patients who are critically ill with COVID-19 and …
by … for using anakinra in the treatment of patients who are critically ill with COVID-19 and …
相关搜索
- patients with covid 19
- covid 19 meta analysis
- severe covid 19 pneumonia
- covid 19 cohort study
- covid 19 safety of anakinra
- covid 19 ards
- covid 19 critically ill patients
- covid 19 receptor antagonist anakinra
- severe forms of covid 19
- management of severe covid 19 patients
- pulmonary intravascular coagulopathy in covid 19
- cytokine storm of covid 19
- severe covid 19 disease
- covid 19 systematic review
- covid 19 interleukin 6 inhibition
- covid 19 high dose anakinra